Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H10O3 |
| Molecular Weight | 154.1632 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCC1=CC(O)=C(O)C=C1
InChI
InChIKey=JUUBCHWRXWPFFH-UHFFFAOYSA-N
InChI=1S/C8H10O3/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,9-11H,3-4H2
| Molecular Formula | C8H10O3 |
| Molecular Weight | 154.1632 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Hydroxytyrosol is an important phenolic compound obtained from olive oil. Hydroxytyrosol possesses anti-inflammatory properties and has the capacity to inhibit cyclooxygenase and lipoxygenase enzymes. Hydroxytyrosol is a powerful antioxidant due to its protective function in cells. Hydroxytyrosol protects the cardiovascular system, avoiding oxidation of LDL cholesterol, maintaining normal blood HDL cholesterol concentrations and thus preventing atherosclerosis. Hydroxytyrosol protects brain cells from lipid peroxidation because it easy penetrates through the blood-brain barrier. Thus, the compound can be used in the disease treatment of Alzheimer or Parkinson. In addition, the compound also helps to prevent osteoporosis because its consumption has positive effects on the formation and growth of bones. Hydroxytyrosol is under investigation phase II clinical trials for breast cancer women to evaluate its effect on mammographic density. The recently published article has shown hydroxytyrosol could prevent obesity and insulin resistance by altering the composition of the intestinal microbiota and improving the integrity of the intestinal wall.
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL215 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24568174 |
13.0 µM [IC50] |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Diverse effects of natural antioxidants on cyclosporin cytotoxicity in rat renal tubular cells. | 2005-08 |
|
| Relationships between oxidative stability, triacylglycerol composition, and antioxidant content in olive oil matrices. | 2005-07-13 |
|
| Fluorescence spectroscopy for monitoring deterioration of extra virgin olive oil during heating. | 2005-07 |
|
| Kinetic study of the physicochemical and microbiological changes in "seasoned" olives during the shelf-life period. | 2005-06-29 |
|
| Effect of the conservation procedure on the contents of phenolic compounds and organic acids in chanterelle (Cantharellus cibarius) mushroom. | 2005-06-15 |
|
| Separation and identification of phenolic compounds in olive oil by coupling high-performance liquid chromatography with postcolumn solid-phase extraction to nuclear magnetic resonance spectroscopy (LC-SPE-NMR). | 2005-06-15 |
|
| Hydroxytyrosol, a phenolic compound from virgin olive oil, prevents macrophage activation. | 2005-06 |
|
| Alpha-tocopherol oxidation in fish muscle during chilling and frozen storage. | 2005-05-18 |
|
| A thromboxane effect of a hydroxytyrosol-rich olive oil wastewater extract in patients with uncomplicated type I diabetes. | 2005-05 |
|
| Interactions of ferric ions with olive oil phenolic compounds. | 2005-04-06 |
|
| Hydroxytyrosol, a natural antioxidant from olive oil, prevents protein damage induced by long-wave ultraviolet radiation in melanoma cells. | 2005-04-01 |
|
| [Studies on chemical constituents from the corm of Cremastra appendiculata]. | 2005-04 |
|
| Secoiridoids, tocopherols, and antioxidant activity of monovarietal extra virgin olive oils extracted from destoned fruits. | 2005-02-23 |
|
| Antioxidant activity of olive phenols: mechanistic investigation and characterization of oxidation products by mass spectrometry. | 2005-02-07 |
|
| Activity of olive oil phenols on lymphomonocyte cytosolic calcium. | 2005-02 |
|
| Radical scavenging potential of phenolic compounds encountered in O. europaea products as indicated by calculation of bond dissociation enthalpy and ionization potential values. | 2005-01-26 |
|
| Identification and antioxidant potential of flavonoids and low molecular weight phenols in olive cultivar chemlali growing in Tunisia. | 2005-01-26 |
|
| Antioxidant and anti-atherogenic activities of olive oil phenolics. | 2005-01 |
|
| Characterization of a new tyrosinase from Pycnoporus species with high potential for food technological applications. | 2005 |
|
| Phenolic compounds in olive oils intended for refining: formation of 4-ethylphenol during olive paste storage. | 2004-12-29 |
|
| Olive oil and modulation of cell signaling in disease prevention. | 2004-12 |
|
| Qualitative and semiquantitative analysis of phenolic compounds in extra virgin olive oils as a function of the ripening degree of olive fruits by different analytical techniques. | 2004-11-17 |
|
| Antioxidant effect of hydroxytyrosol, a polyphenol from olive oil: scavenging of hydrogen peroxide but not superoxide anion produced by human neutrophils. | 2004-11-15 |
|
| The toxicity profile of hydrolyzed aqueous olive pulp extract. | 2004-11 |
|
| Acid-induced structural modifications of unsaturated Fatty acids and phenolic olive oil constituents by nitrite ions: a chemical assessment. | 2004-10 |
|
| Total recovery of the waste of two-phase olive oil processing: isolation of added-value compounds. | 2004-09-22 |
|
| [Assessment of the in vitro and in vivo toxicity of 3,4-dihydroxyphenylacetaldehyde (DOPAL)]. | 2004-09 |
|
| Comparative study on phenolic content and antioxidant activity during maturation of the olive cultivar Chemlali from Tunisia. | 2004-08-25 |
|
| Olives and olive oil in cancer prevention. | 2004-08 |
|
| Acylated flavonoids and phenol glycosides from Veronica thymoides subsp. pseudocinerea. | 2004-08 |
|
| Removal of monomeric phenols in dry mill olive residue by saprobic fungi. | 2004-07-14 |
|
| Production of highly purified hydroxytyrosol from Olea europaea leaf extract biotransformed by hyperthermophilic beta-glycosidase. | 2004-07-01 |
|
| Low-molecular-weight components of olive oil mill waste-waters. | 2004-06-19 |
|
| Antifungal constituents of Clytostoma ramentaceum and Mansoa hirsuta. | 2004-06 |
|
| Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation--a randomized controlled trial. | 2004-06 |
|
| Bioavailability and antioxidant effects of olive oil phenols in humans: a review. | 2004-06 |
|
| Polyphenol changes during fermentation of naturally black olives. | 2004-04-07 |
|
| Depsides from the petals of Papaver rhoeas. | 2004-04 |
|
| An endogenous metabolite of dopamine, 3,4-dihydroxyphenylethanol, acts as a unique cytoprotective agent against oxidative stress-induced injury. | 2004-03-01 |
|
| Toxicity of a treatment associating dopamine and disulfiram for catecholaminergic neuroblastoma SH-SY5Y cells: relationships with 3,4-dihydroxyphenylacetaldehyde formation. | 2004-03 |
|
| Effect of cultivar and processing method on the contents of polyphenols in table olives. | 2004-02-11 |
|
| [Isolation and structural identification of C-glycosylflavones from Corallodiscus flabellata]. | 2004-02 |
|
| Toward a high yield recovery of antioxidants and purified hydroxytyrosol from olive mill wastewaters. | 2004-01-28 |
|
| Biogenic amine formation and "zapatera" spoilage of fermented green olives: effect of storage temperature and debittering process. | 2004-01 |
|
| Bioavailability of phenolic compounds from olive oil and oxidative/antioxidant status at postprandial state in healthy humans. | 2004 |
|
| Antioxidant effect of phenolic compounds, alpha-tocopherol, and other minor components in virgin olive oil. | 2003-11-19 |
|
| 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis. | 2003-11-07 |
|
| Fast separation and determination of tyrosol, hydroxytyrosol and other phenolic compounds in extra-virgin olive oil by capillary zone electrophoresis with ultraviolet-diode array detection. | 2003-09-05 |
|
| Oxidative transformation of phenols in aqueous mixtures. | 2003-07 |
|
| In vitro formation of quinoid metabolites of the dietary supplement Cimicifuga racemosa (black cohosh). | 2003-07 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/30884808
Hydroxytyrosol (HT) exert cardioprotective and anti-atherosclerotic effects. This study evaluates the effect of oral supplementation with HT on early atherosclerosis markers in middle-aged, seemingly healthy adults. The supplement was composed of 9.9 mg of HT
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:13:24 GMT 2025
by
admin
on
Mon Mar 31 19:13:24 GMT 2025
|
| Record UNII |
QEU0NE4O90
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C275
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
||
|
DSLD |
3475 (Number of products:12)
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
||
|
NCI_THESAURUS |
C1327
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
600
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
PRIMARY | |||
|
68889
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
PRIMARY | |||
|
QEU0NE4O90
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
PRIMARY | |||
|
1314227
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
PRIMARY | RxNorm | ||
|
DTXSID70147451
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
PRIMARY | |||
|
100000175320
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
PRIMARY | |||
|
HYDROXYTYROSOL
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
PRIMARY | |||
|
QEU0NE4O90
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
PRIMARY | |||
|
m6157
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
PRIMARY | Merck Index | ||
|
DB12771
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
PRIMARY | |||
|
C63690
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
PRIMARY | |||
|
82755
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
PRIMARY | |||
|
876
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
PRIMARY | |||
|
10597-60-1
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
PRIMARY | |||
|
837
Created by
admin on Mon Mar 31 19:13:24 GMT 2025 , Edited by admin on Mon Mar 31 19:13:24 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
|